Does Rallies show Form 4 insider transactions for OHI?

Yes. Rallies tracks OHI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is OHI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OHI. It does not provide personalized investment advice.

OHI (Omega Healthcare Investors Inc.) Stock Analysis - Insider Trades

Omega Healthcare Investors Inc. (OHI) is a publicly traded Real Estate sector company. As of May 21, 2026, OHI trades at $48.80 with a market cap of $14.39B and a P/E ratio of 23.54. OHI moved +0.53% today. Year to date, OHI is +12.00%; over the trailing twelve months it is +30.57%. Its 52-week range spans $35.04 to $49.33. Analyst consensus is buy with an average price target of $50.22. Rallies surfaces OHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading OHI stock inside the company?

Recent OHI insider activity includes Gupta Vikas bought 11.50K, PICKETT C TAYLOR bought 20.00K, Egbuonu-Davis Lisa sold 200, and Egbuonu-Davis Lisa sold 2.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

OHI Key Metrics

Key financial metrics for OHI
Metric	Value
Price	$48.80
Market Cap	$14.39B
P/E Ratio	23.54
EPS	$2.08
Dividend Yield	0.67%
52-Week High	$49.33
52-Week Low	$35.04
Volume	149
Avg Volume	0
Revenue (TTM)	$1.24B
Net Income	$655.98M
Gross Margin	0.00%

Recent OHI Insider Trades

Gupta Vikas bought 11.50K (~$494.12K) on Nov 6, 2025.
PICKETT C TAYLOR bought 20.00K (~$862.86K) on Nov 5, 2025.
Egbuonu-Davis Lisa sold 200 (~$8.03K) on Aug 8, 2025.
Egbuonu-Davis Lisa sold 2.30K (~$92.36K) on Aug 8, 2025.

Latest OHI News

Omega Healthcare Investors jumps as traders position ahead of April 28 earnings — Apr 23, 2026
Omega Healthcare Investors Secures Buy Rating; Stakes Raised by 5.6% and 3.4% — Apr 14, 2026
Omega Healthcare Investors Trades at 14.6x P/E, 1.47 PEG and 2.58 P/B with D Value Grade — Mar 4, 2026
Omega Healthcare Sees 2.5% Q4 NOI Growth, 83.1% Occupancy and $100M Financing — Feb 7, 2026
Omega Healthcare’s Q4 Net Income Climbs 48%, Completes $334M Investments — Feb 5, 2026

OHI Analyst Consensus

10 analysts cover OHI: 0 strong buy, 4 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $50.22.

Common questions about OHI

Who is trading OHI stock inside the company?: Recent OHI insider activity includes Gupta Vikas bought 11.50K, PICKETT C TAYLOR bought 20.00K, Egbuonu-Davis Lisa sold 200, and Egbuonu-Davis Lisa sold 2.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for OHI?: Yes. Rallies tracks OHI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is OHI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OHI. It does not provide personalized investment advice.